Analysis of target genes induced by IL-13 cytotoxin in human glioblastoma cells
Cite this article as: Han, J., Yang, L. & Puri, R.K. J Neurooncol (2005) 72: 35. doi:10.1007/s11060-004-3119-7 Abstract
IL-13 cytotoxin comprised of IL-13 and a mutated form of
Pseudomonas exotoxin (fusion protein termed IL-13-PE38QQR) has been shown to inhibit protein synthesis leading to necrotic and apoptotic cell death in glioblastoma cells that express high levels of interleukin-13 receptors (IL-13R). To identify target genes of cell death and other cellular genes with IL-13 receptors in glioblastoma cells, we utilized the cDNA microarrays to analyze global gene expression profiles after IL-13 cytotoxin and IL-13 treatment. IL-13 cytotoxin mediated cytotoxicity to U251 cells in a dose-dependant manner. Hierarchical cluster analysis of differentially expressed genes in U251 glioma cells at different time points after IL-13 cytotoxin treatment showed three major groups, each representing a specific expression pattern. Randomly selected differentially expressed genes from each group were confirmed by RT-PCR analysis. Most down-regulated genes belong to cell adhesion, motility, angiogenesis, DNA repair, and metabolic pathways. While up-regulated genes belong to cell cycle arrest, apoptosis, signaling and various metabolic pathways. Unexpectedly, at early time points, both IL-13 and IL-13 cytotoxin induced several genes belonging to different pathways most notably IL-8, DIO2, END1, and ALDH1A3 indicating that these genes are early response genes and their products may be associated with IL-13R. In addition, IL-13 cytotoxin induced IL-13R α2 mRNA expression during the treatment in glioma cells. Our results indicate that novel cellular genes are involved with IL-13 receptors and that IL-13 cytotoxin induced cell death involves various target genes in human glioblastoma cells. On going studies will determine the role of associated genes and their products in the IL-13R functions in glioma cells. Keywords cDNA microarray gene expression profiles IL-13 cytotoxin IL-13R α2 receptor References
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg LX, Edwards BK (eds) SEERS Cancer Statistics Review, 1973–1997, National cancer Institute. NIH Pub. No. 00-2789. Bethesda, MD 2000.
Puri, RK, Leland, P, Kreitman, RJ, Pastan, I 1994 Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL-4 Pseudomonas exotoxin chimeric protein Int J Cancer 58 574 581 Google Scholar Laske, DW, Youle, RJ, Oldfield, EH 1997 Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors Nature Med 3 1362 1368 Google Scholar Hao, CH, Parney, IF, Roa, WH, et al. 2002 Cytokine and cytokine receptor mRNA expression in human glioblastoma: evidence of Th1, Th2 and Th3 cytokine dysregulation Acta Neuropathol 103 171 178 Google Scholar Obiri, NI, Debinski, W, Leonard, WJ, Puri, RK 1995 Receptor for interleukin 13: interaction with interleukin 4 by a mechanism that dose not involve the common γ chain shared by receptors for interleukin 2, 4, 7, 9, and 15 J Biol Chem 270 8797 8804 Google Scholar Debinski, W, Obiri, NI, Powers, SK, Pastan, I, Puri, RK 1995 Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin Clin Cancer Res 1 1253 1258 Google Scholar Husain, SR, Obiri, NI, Gill, P, Zhang, T, Pastan, I, Debinski, W, Puri, RK 1997 Receptor for interleukin 13 on AIDS-associated Kaposi’s sarcoma cells serves as a new target for poten Pseudomonas exotoxin-based chimeric toxin protein Clin Cancer Res 3 151 156 Google Scholar Joshi, BH, Plautz, GE, Puri, RK 2000 Interleukin-13 receptor a chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas Cancer Res 60 1168 1172 Google Scholar Husain, SR, Joshi, BH, Puri, RK 2001 Interleukin-13 receptor as a unique target for anti-glioblastoma therapy Int J Cancer 92 168 175 Google Scholar Hilton, DJ, Zhang, JG, Metcalf, D, Alexander, WS, Nicola, NA, Willson, TA 1996 Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor Proc Natl Acad Sci USA 93 497 501 Google Scholar Aman, MJ, Tayebi, N, Obiri, NI, Puri, RK, Modi, WS, Leonard, WJ 1996 cDNA cloning and characterization of the human interleukin 13 receptor alpha chain J Biol Chem 271 29265 29270 Google Scholar Murata, T, Obiri, NI, Puri, RK 1998 Structure of and signal transduction through interleukin-4 and interleukin-13 receptors Int J Mol Med 1 551 557 Google Scholar Miloux, B, Laurent, P, Bonnin, O, et al. 1997 Cloning of the human IL-13Rα1chain and reconstitution with the IL-4Rα of a functional IL-4/Il-13 receptor complex FEBS Lett 401 163 166 Google Scholar Orchansky, PL, Kwan, R, Lee, F, Schrader, JW 1999 Characterization of the cytoplasmic domain of interleukin-13 receptor-α J Biol Chem 274 20818 20825 Google Scholar Caput, D, Laurent, P, Kaghad, M, et al. 1996 Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α. chain. J Biol Chem 271 16921 16926 Google Scholar Kawakami, K, Taguchi, J, Murata, T, Puri, RK 2001 The interleukin-13 receptor α2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through STAT6 pathway Blood 97 2673 2679 Google Scholar Kawakami, K, Takeshita, F, Puri, RK 2001 Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain J Biol Chem 276 25114 25120 Google Scholar Debinski, W, Obiri, NI, Pastan, I, Puri, RK 1995 A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4 J Biol Chem 270 16775 16780 Google Scholar Joshi, BH, Kawakami, K, Leland, P, Puri, RK 2002 Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin Clin Cancer Res 8 1948 1956 Google Scholar Puri, RK, Leland, P, Obiri, NI, Husain, SR, Kreitman, RJ, Haas, GP, Pastan, I, Debinski, W 1996 Targeting of IL-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated from of Pseudomonas exotoxin A (PE38QQR) Blood 87 4333 4339 Google Scholar Husain, SR, Puri, RK 2000 Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi’s sarcoma xenograft Blood 95 3506 3513 Google Scholar Kawakami, K, Husain, SR, Kawakami, M, Puri, RK 2002 Improved anti-tumor activity and safety of interleukin-13 receptor targeted cytotoxin by systemic continuous administration in head and neck cancer xenograft model Mol Med 8 487 494 Google Scholar Kawakami, K, Kawakami, M, Puri, RK 2002 Cytokine receptor as a sensitizer for targeted cancer therapy Anti-Cancer Drugs 13 693 699 Google Scholar Kawakami, M, Kawakami, K, Puri, RK 2002 Intratumor administration of interleukin 13 receptor-targeted cytotoxin induces apoptotic cell death in human malignant glioma tumor xenografts Mol Cancer Therap 1 999 1007 Google Scholar Kawakami, K, Joshi, BH, Puri, RK 2000 Sensitization of cancer cells to interleukin 13-Pseudomonas exotoxin-induced cell death by gene transfer of interleukin 13 receptor a chain Human Gene Therapy 11 1829 1835 Google Scholar
Weingart J, Grossman SA, Bohan E, Fisher JD, Strauss L, Puri RK: Phase I/II study of interstitial infusion of IL13-PE38QQR cytotoxin in recurrent malignant glioma. First Quadrennial meeting – World Federation of Neuro-Oncology, November 15–17, 2001, Washington, DC.
Weingart, J, Strauss, LC, Grossman, SA, Markett, J, Tatter, S, Fisher, JD, Fleming, CK, Puri, RK 2002 Phase I/II study: intra-tumoral infusion of IL13-PE38QQR cytotoxin for recurrent supratentorial malignant glioma. Neoro-oncol 4 379 Google Scholar
Prados MD, Lang FF, Strauss L, Fleming C, Alalpe K, Kunwar S, Yung WKA, Chang S, Husain SR, Gutin PH, Raizer J, Piepmeier JM, Berger M, McDermott M, Puri RK: Intratumoral and intracerebral microinfusion of IL13-PE38QQR cytotoxin: phase I/II study of pre- and post-resection infusions in recurrent resectable malignant glioma. Proc. Am. Soc. Clin. Oncol. 21, 69 (Abstract 2087), 2002.
Lang F, Kunwar S, Strauss L, Gutin P, Piepmeier J, McDermott M, Fleming C, Sherman J, Raizer J, Alalpe K, Yung WKA, Husain SR, Chang S, Berger M, Prados M, Puri RK: A clinical study of convection-enhanced delivery of IL13-PE38QQR cytotoxin Pre- and post- resection of recurrent GBM. American Society of Neuro-Oncologists Chicago, April 2002.
Prados MD, Lang FF, Sherman JW, Strauss LC, Fleming CK, Alalpe K, Kunwar S, Yung WKA, Chang SM, Husain SR, Gutin PH, Raizer J, Piepmeier JM, Berger M, McDermott M, Puri RK: Convection-enhanced delivery (CED) by positive pressure infusion for intra- tumoral and peri-tumoral administration of IL13-PE38QQR a recombinant tumor-targeted cytotoxin in recurrent malignant glioma. Neuro-Oncol 4: S78, 2002(B).
Schena, M, Shalon, D, Davis, RW, Brown, PO 1995 Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 270 467 470 PubMed Google Scholar Bowtell, DDL 1999 Options available- from start to finish-for obtaining expression data by microarray Nat Genet 21 25 32 Google Scholar Pollack, JR, Perou, CM, Alizadeh, AA, Eisen, MB, Pergamenschikov, A, Williams, CF, Jeffrey, SS, Botstein, D, Brown, PO 1999 Genome-wide analysis of DNA copy-number changes using cDNA microarrays Nat Genet 23 41 46 Google Scholar King, HC, Sinha, AA 2001 Gene expression profile analysis by DNA microarray JAMA 286 2280 2288 Google Scholar Shoemaker, DD, Schadt, EE, Armour, CD, He, YD, Garrett-Engele, P, McDonagh, PD, Loerch, PM, Leonardson, A, Lum, PY, Cavet, G, Wu, LF, Altschuler, SJ, Edwards, S, King, J, Tsang, JS, Schimmack, G, Schelter, JM, Koch, J, Ziman, M, Marton, MJ, Li, B, Cundiff, P, Ward, T, Castlw, J, Krolewski, M, Meyer, MR, Mao, M, Burchard, J, Kidd, MJ, Dal, H, Pillips, JW, Linsley, PS, Stoughton, R, Scherer, S, Bouguski, MS 2001 Experimental annotation of the human genome using microarray technology Nature 409 922 927 Google Scholar Veer, LJ, Dai, H, Vijver, MJ, He, YD, Hart, AAM, Mao, M, Peterse, HL, Kooy, KV, Marton, MJ, Witteveen, AT, Schreiber, GJ, kerkhoven, RM, Roberts, C, Linsley, PS, Bernards, R, Friend, SH 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 530 536 CrossRef PubMed Google Scholar Brazma, A, Higamp, P, Quackenbush, J, Sherlock, G, Spellman, P, Stoeckert, C, Aach, J, Anssorge, W, Ball, CA, Causton, HC, Gaasterland, T, Glenisson, P, Holstege, FCP, Kim, IF, Markowitz, V, Matese, JC, Parkinson, H, Robinson, A, Sarkans, U, Schulze-Kremer, S, Stewart, J, Taylor, R, Vilo, J, Vingron, M 2001 Minimum information about a microarray experiment (MIAME)-toward standards for microarray data Nat Genet 29 365 371 CrossRef Google Scholar Calvo, A, Xiao, N, Kang, J, Best, CJ, Leiva, I, Emmert-Buck, MR, Jorcyk, C, Green, JE 2002 Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors Cancer Res 62 5325 5335 Google Scholar Risinger, JI, Maxwell, GL, Chandramouli, GV, Jazaeri, A, Aprelikova, O, Patterson, T, Berchuck, A, Barrett, JC 2003 Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer Cancer Res 63 6 11 Google Scholar Irvine, AD, Christiano, AM 2001 Hair on a gene string: recent advances in understanding the molecular genetics of hair loss Clin Exp Dermatol 26 59 71 Google Scholar Sargiannidou, I, Zhou, J, Tuszynski, GP 2001 The role of thrombospondin-1 in tumor progression Exp Biol Med 226 726 733 Google Scholar Montfort, WR, Weichsel, A 1997 Thymidylate synthase: structure, inhibition, and strained conformations during catalysis Pharmacol Ther 76 29 43 Google Scholar Babic, AM, Kireeva, ML, Kolesnikova, TV, Lau, LF 1998 CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth PNAS USA 95 6355 6360 Google Scholar Wagner, M, Klussmann, JP, Fangmann, R, Linder, R, Elewa, ME, Eidt, S, Rose, VM, Jungehulsing, M, Schulze, HJ 2001 Cyclin-dependent kinase-inhibitor 1 (CDKN1A) in the squamous epithelium of the oropharynx: possible implications of molecular biology and compartmentation Anticancer Res 21 333 334 Google Scholar Zhou, R, Diehl, D, Hoeflich, A, Lahm, H 2003 IGF-binding protein-4: biochemical characteristics and functional consequences J Endocrinol 178 177 193 PubMed Google Scholar Heinrich, PC, Behrmann, I, Haan, S, Hermanns, HM, Muller-Newen, G, Schaper, F 2003 Principles of interleukin (IL)-6-type cytokine signalling and its regulation Biochem J 374 1 20 Google Scholar Zhang, W, Bae, I, Krishnaraju, K, Azam, N, Fan, W, Smith, K, Hoffman, B, Leibermann, DA 1999 CR6: A third member in the MyD118 and Gadd 45 family which functions in negative growth control Oncogene 18 749 757 Google Scholar Smith, ML, Ford, JM, Hollander, MC, Bortnick, RA, Amundson, SA, Seo, YR, Deng, CX, Hanawalt, PC, Fornace, AJ 2000 p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and /or gadd45 genes Mol Cell Biol 20 3705 3714 Google Scholar Harkin, DP, Bean, JM, Miklos, D, Song, YH, Truong, VB, Englert, C, Christians, FC, Ellison, LW, Maheswaran, S, Oliner, JD, Haber, DA 1999 Induction of GADD45 and JNK/SARK-dependent apoptosis following inducible expression of BRC1 Cell 97 575 586 Google Scholar Liebermann, DA, Hoffman, B 2002 Myeloid differentiation (MyD)/growth arrest DNA damage (GADD) genes in tumor suppression, immunity and inflammation Leukemia 16 527 541 Google Scholar Aschele, C, Lonardi, S, Monfardini, S 2002 Thymidylate synthase expression as a predictor of clinical response to fluoropyrimidine-base chemotherapy in advanced colorectal cancer Cancer Treat Rev 28 27 47 CrossRef PubMed Google Scholar Chen, H, Herndon, ME, Lawler, J 2000 The cell biology of thrombospondin-1 Matrix Biol 19 597 614 Google Scholar Blease, K, Jakubzick, C, Schuh, JM, Joshi, BH, Puri, RK, Hogaboam, CM 2001 IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice J Immunol 167 6583 6592 Google Scholar Murata, T, Noguchi, PD, Puri, RK 1996 Il-13 induces phosphorylation and activation of JAK2 janus kinase in human colon carcinoma cell line J Immunol 156 2972 2978 Google Scholar Krebs, DL, Hilton, DJ 2000 SOCS: physiological suppressors of cytokine signaling. J Cell Sci 113 2813 2819 PubMed Google Scholar Weaver, M, Laske, DW 2003 Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas J Neuro Oncol 65 3 13 Google Scholar Muldoon, LL, Neuwelt, EA 2003 BR96-DOX immunoconjugate targeting of chemotherapy in brain tumor models J Neuro Oncol 65 49 62 Google Scholar Kawakami, M, Kawakami, K, Puri, RK 2003 Interleukin-4 Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy J Neuro Oncol 65 15 25 Google Scholar Guo, N, Zabrenetzky, VS, Chandrasekaran, L, Sipes, JM, Lawler, J, Krutzsch, HC, Roberts, DD 1998 Differential roles of protein kinase C and pertussis toxin-sensitive G-binding proteins in modulation of melanoma cell proliferation and motility by thrombospondin-1 Cancer Res 58 3154 3162 Google Scholar Volpert, OV, Lawler, J, Bouck, NP 1998 A human fibrosacoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1 Proc Natl Acad Sci USA 95 6343 6348 Google Scholar